famotidine has been researched along with Leukopenia in 1 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
Leukopenia: A decrease in the number of LEUKOCYTES in a blood sample below the normal range (LEUKOCYTE COUNT less than 4000).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liersch, T | 1 |
| Beyer, JH | 1 |
| Krieger, G | 1 |
| Vehmeyer, K | 1 |
1 other study available for famotidine and Leukopenia
| Article | Year |
|---|---|
The growth capacity of hematopoietic progenitor cells in severe neutropenia induced by famotidine.
Topics: Adult; Bone Marrow; Bone Marrow Cells; Cell Division; Cells, Cultured; Colony-Forming Units Assay; D | 1992 |